C25 C22 C24 C15
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Previous surgical procedure (pancreas, liver, esophagus, or sarcoma) performed within a standardized ERAS protocol (within the last 36 months), with a signed biobank consent form available (PV3548). • Capacity to provide informed consent. • Agreement to be contacted and to participate in the study.
Exclusion criteria
Exclusion criteria: • Severe cognitive impairments. • Language barriers if the app and questionnaire are not understandable. • No possibility to use digital devices (smartphone, tablet, or PC).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Perceived usefulness of the app for optimizing the recovery process within the ERAS concept (assessed retrospectively) (TAM-PU and ERAS-specific questionnaires). time point: single assessment after completion of recovery at the time of study participation, 1–36 months after surgery; measured using TAM-PU and ERAS-specific questionnaires). | — |
Secondary
| Measure | Time frame |
|---|---|
| Usability and user-friendliness of the app measured using the G-MAUQ. Technical issues (e.g., app crashes). Affinity for Technology Interaction (ATI). Evaluation of individual content components (e.g., videos, daily goals, interactive features) using uMARS. Participants’ suggestions for improvement. Response rate and dropout rate as measures of feasibility. Qualitative assessment of the app by the ERAS team (medical and nursing staff) using MARS. Qualitative assessment of the app by patients using uMARS. | — |
Countries
Germany
Contacts
Universitätsklinikum Hamburg-Eppendorf